Feener Edward P. — SEC Form 4 filings
SEC reporting owner CIK 1691090. 6 Form 4 filings on record with FilingPulse; latest filed 2024-05-21.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-01-10 to 2024-05-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 8 legs across 5 filings — 104,547 shares, $1,436,722 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: sale of 28,171 shares @ $15.01 ($422,827) in KalVista Pharmaceuticals, Inc., filed 2024-02-16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| KalVista Pharmaceuticals, Inc. (KALV) | CHIEF SCIENTIFIC OFFICER | 6 | — | 8 legs · 104,547 sh · $1,436,722 | 12 |
Form 4 filings — Feener Edward P.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2024-05-21 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Option exercise (M): 18,789 · Sale (S): 8,088 @ $11.76 · Option exercise (M): 1,774 (derivative) @ $0 · Option exercise (M): 2,431 (derivative) @ $0 · Option exercise (M): 7,292 (derivative) @ $0 · Option exercise (M): 7,292 (derivative) @ $0 | EDGAR |
| 2024-02-21 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Option exercise (M): 18,788 · Sale (S): 8,397 @ $14.11 · Sale (S): 19,591 @ $14.04 · Sale (S): 300 @ $14.72 · Option exercise (M): 1,774 (derivative) @ $0 · Option exercise (M): 2,430 (derivative) @ $0 · +2 more | EDGAR |
| 2024-02-16 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Sale (S): 28,171 @ $15.01 | EDGAR |
| 2024-02-13 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Grant/award (A): 60,000 · Grant/award (A): 29,167 (derivative) @ $0 | EDGAR |
| 2024-01-12 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Sale (S): 22,679 @ $13.03 | EDGAR |
| 2024-01-10 | 4 | KalVista Pharmaceuticals, Inc. (KALV) | Sale (S): 17,221 @ $13.01 · Sale (S): 100 @ $13 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-10 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1691090 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →